canagliflozin Articles
FDA panel backs J&J diabetes drug Invokana (canagliflozin)
11 January 2013
Janssen files for EU approval of canagliflozin in type 2 diabetes; Ferrer pulls Egrifta MAA
27 June 2012
Showing 1-7 of 7 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
